Sign up
Pharma Capital

WeedMD closes its fund-raising with full exercise of the over-allotment option

In all, 16.05mln units were sold at a price of $2.15 each.
Canadian dollars
WeedMD raised C$34.5mln (gross) from the issue

WeedMD Inc (CVE:WMD), a producer and distributor of medical cannabis, has closed its short form prospectus offering, including the full exercise of the over-allotment option.

In all, 16.05mln units were sold at a price of $2.15 each.

READ WeedMD increases size of its equity financing​

Each unit consists of a share and a half a warrant; the two halves of a warrant together entitle the holder to purchase a WeedMD common share at C$2.90 anytime before 11 January, 2020.

WeedMD shares currently trade at C$2.35, down 22 cents on the day.

The company intends to use the net proceeds of the offering to expand its lease footprint and retrofitting plans and operations at its 14-acre Strathroy Greenhouse; to purchase and further develop its Aylmer Facility; to pursue potential strategic domestic and international opportunities; and for working capital and general corporate purposes. 

Why Invest In WeedMD? Read More Here

Register here to be notified of future WMD Company articles
View full WMD profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.